Participants 624 689 4
patients with IBS and a study conducted in healthy male subjects.
Participants 786 888 7
2516 IBS patients with symptoms of abdominal pain and constipation received tegaserod 2 or 6 mg b.i.d.
Participants 932 1048 4
In an additional study, 36 healthy male subjects received iv. single doses of tegaserod (0.8 mg to 20 mg) or placebo
